This conclusion is consistent with previously published data showing that FXYD5 overexpression in breast cancer cells induces the phosphorylation of AKT (38), which promotes the transcriptional activity of NF-κB-responsive promoter elements and increases levels of CCL2 mRNA (38, 41). Here, AKT1 is linked to breast cancer.